TE_1270
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 317.84 |
| Counts of samples | TCGA_tumor:281; TCGA_normal:0; GTEx:0 |
| TSS | chr1(-):164459589 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_1270.11 | - | Intergenic | Non-coding | Non-coding | chr1(-):164410764,164410784,164449657,164449734,164459194,164459590 |
| teRNA_1270.12 | - | Intergenic | Non-coding | Non-coding | chr1(-):164453213,164453233,164459194,164459590 |
| teRNA_1270.13 | - | Intergenic | Non-coding | Non-coding | chr1(-):164196309,164196329,164459194,164459590 |
| teRNA_1270.14 | - | Intergenic | Non-coding | Non-coding | chr1(-):164428883,164428903,164459194,164459590 |
| teRNA_1270.15 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427330,164427350,164459194,164459590 |
| teRNA_1270.16 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427646,164427666,164428757,164428903,164430645,164430796,164459194,164459590 |
| teRNA_1270.17 | - | Intergenic | Non-coding | Non-coding | chr1(-):164430776,164430796,164459194,164459590 |
| teRNA_1270.18 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427646,164427666,164459194,164459590 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
